Pages that link to "Q42551802"
Jump to navigation
Jump to search
The following pages link to Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine (Q42551802):
Displaying 24 items.
- EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. (Q33292103) (← links)
- Low rejection rates with tacrolimus-based dual and triple regimens following liver transplantation (Q33337598) (← links)
- Cyclosporin-induced hypertension: incidence, pathogenesis and management (Q33646906) (← links)
- A practical guide to the management of hypertension in renal transplant recipients (Q33826211) (← links)
- Applications of tacrolimus for the treatment of skin disorders (Q33957194) (← links)
- Hypertension after renal transplantation (Q34365108) (← links)
- Hypertension after Kidney Transplantation: Impact, Pathogenesis and Therapy (Q35107206) (← links)
- Calcium channel blockers as the treatment of choice for hypertension in renal transplant recipients: fact or fiction. (Q35160258) (← links)
- Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk (Q35876331) (← links)
- Antihypertensive agents and renal transplantation. (Q36768632) (← links)
- Hypertension in the kidney transplant recipient. (Q37764468) (← links)
- Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation (Q38047203) (← links)
- Hypertension after kidney transplantation: a pathophysiologic approach (Q38128162) (← links)
- Withdrawal of immunosuppression in liver allograft recipients (Q41752432) (← links)
- A new donors' CYP3A5 and recipients' CYP3A4 cluster predicting tacrolimus disposition, and new-onset hypertension in Chinese liver transplant patients (Q42378424) (← links)
- Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight (Q43666887) (← links)
- Cardiovascular risk factors and late cardiovascular disease in liver transplantation (Q43977868) (← links)
- Biodegradable microsphere-loaded tacrolimus enhanced the effect on mice islet allograft and reduced the adverse effect on insulin secretion (Q43985629) (← links)
- Late hypertension after liver transplantation: a comparison of cyclosporine and tacrolimus (FK 506). (Q50878999) (← links)
- Hypertension guidelines: How do they apply to kidney transplant recipients (Q57190615) (← links)
- Hypertension: The Neglected Complication of Transplantation (Q58992876) (← links)
- Posttransplant hypertension (Q77176622) (← links)
- Posttransplant metabolic syndrome: New evidence of an epidemic and recommendations for management (Q83286398) (← links)
- Approach and Management of Hypertension After Kidney Transplantation (Q96954772) (← links)